IGI INC
10-Q, EX-27.2, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: IGI INC, 10-Q, EX-27.1, 2000-11-14
Next: NORTH VALLEY BANCORP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                           1,051
<SECURITIES>                                         0
<RECEIVABLES>                                    6,733
<ALLOWANCES>                                       555
<INVENTORY>                                      7,797
<CURRENT-ASSETS>                                17,191
<PP&E>                                          20,900
<DEPRECIATION>                                (11,328)
<TOTAL-ASSETS>                                  32,741
<CURRENT-LIABILITIES>                           26,355
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            97
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    32,741
<SALES>                                         24,982
<TOTAL-REVENUES>                                26,389
<CGS>                                           13,395
<TOTAL-COSTS>                                   11,612
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,500
<INCOME-PRETAX>                                (1,118)
<INCOME-TAX>                                       333
<INCOME-CONTINUING>                              (785)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (785)
<EPS-BASIC>                                      (.08)
<EPS-DILUTED>                                    (.08)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission